Uncategorized

Peer reviewed publications

Quantitative ultrasound for steatosis assessment using Hepatoscope®: Confounding technical factors

Ultraportable Quantitative Ultrasound for Hepatic Steatosis Assessment

Use of Hepatoscope 2DTE for non-invasive assessment of liver stiffness among Mexican immigrant adults in a community-based setting

Hepatoscope 2DTE’s image-based quality index enhances applicability and repeatability of liver stiffness measurement

Posters at National and International conférences

Screening for MASLD Using a Novel Point-of-Care Device, the Hepatoscope, in Diabetology

Quantitative ultrasound for liver steatosis assessment with a new point-of-care device, HepatoScope, is reproducible and showed good correlation to other non-invasive tests.

Liver stiffness measurements with a new point-of-care device, HepatoScope, using two-dimensional transient elastography showed good correlation to other non-invasive tests.

Two-dimensional versus One-dimensional Transient Elastography: Benefitsof Ultrasound Imaging Based Processing for Liver Stiffness Measurements

Liver stiffness measurements with a new point-of-care device, Hepatoscope, using 2Dtransient elastography showed both very good reproducibility and correlation to Fibroscan

Quantitative Ultrasound for Liver Steatosis Assessment: Benefits ofMeasurements Over a Large Two-dimensional Region of Interest on thePerformance of Image-brightness-based Parameters

Real-life burden of viral hepatitis and MASLD in underserved rural communities in Central and North Romania: results from the HE-RO-I project

LSM in patients with MASLD using Hepatoscope® is comparable to Fibroscan® andnot affected by BMI

Good diagnostic performance of Hepatoscope in diabetology clinics for the screening of MASLD patients with high risk of advanced liver fibrosis